Skip to main content
Premium Trial:

Request an Annual Quote

Shall We Call It, Pulitzer Version 2.0?

New York Times science writer Amy Harmon took home the Pulitzer Prize for explanatory journalism on Monday for her series of articles on genetic testing, says Jonathan Eisen at The Tree of Life. "Overall, I like her reporting," Eisen says. "What we all really need to do is convince her to start a blog. Print media is so 21st century." (But, that would mean that Harmon wouldn't be able to win a Pulitzer, even if her blogging was beyond 21st century, or, as a more critical bunch opines, the prizes are in effect "totem poles of the newspaper industry; beloved relics of former glory.")

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.